Follow
Stephanie Reuter Lange
Title
Cited by
Cited by
Year
Carnitine and acylcarnitines: Pharmacokinetic, pharmacological and clinical aspects
SE Reuter, AM Evans
Clinical pharmacokinetics 51 (9), 553-572, 2012
3572012
Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease
AM Evans, RJ Faull, RL Nation, S Prasad, T Elias, SE Reuter, G Fornasini
Kidney international 66 (4), 1527-1534, 2004
762004
Reliability and validity of indices of hand‐grip strength and endurance
SE Reuter, N Massy‐Westropp, AM Evans
Australian occupational therapy journal 58 (2), 82-87, 2011
752011
Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients
SE Reuter, RJ Faull, E Ranieri, AM Evans
Nephrology Dialysis Transplantation 24 (3), 990-996, 2009
612009
Determination of the reference range of endogenous plasma carnitines in healthy adults
SE Reuter, AM Evans, DH Chace, G Fornasini
Annals of clinical biochemistry 45 (6), 585-592, 2008
512008
L‐carnitine supplementation in the dialysis population: Are Australian patients missing out?
SE Reuter, RJ Faull, AM Evans
Nephrology 13 (1), 3-16, 2008
492008
Pharmacokinetics of cannabis in cancer cachexia-anorexia syndrome
SE Reuter, JH Martin
Clinical pharmacokinetics 55 (7), 807-812, 2016
442016
Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease
SE Reuter, AM Evans, RJ Faull, DH Chace, G Fornasini
Annals of clinical biochemistry 42 (5), 387-393, 2005
392005
Long‐chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase‐I activity
SE Reuter, AM Evans
Journal of internal medicine 270 (1), 76-84, 2011
372011
A retrospective study to determine the cefepime-induced neurotoxicity threshold in hospitalized patients
C Lau, D Marriott, M Gould, D Andresen, SE Reuter, J Penm
Journal of Antimicrobial Chemotherapy 75 (3), 718-725, 2020
302020
Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin
SE Reuter, AM Evans, S Shakib, Y Lungershausen, B Francis, G Valentini, ...
Clinical drug investigation 35 (9), 559-567, 2015
252015
Pharmacokinetics of a transdermal testosterone cream in healthy postmenopausal women
E Fooladi, SE Reuter, RJ Bell, PJ Robinson, SR Davis
Menopause 22 (1), 44-49, 2015
202015
Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria
SE Reuter, RN Upton, AM Evans, V Navaratnam, PL Olliaro
Journal of Antimicrobial Chemotherapy 70 (3), 868-876, 2015
172015
Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology
BD Menz, SL Stocker, N Verougstraete, D Kocic, P Galettis, CP Stove, ...
British Journal of Clinical Pharmacology 87 (2), 227-236, 2021
132021
Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure
RV Shingde, SE Reuter, GG Graham, JE Carland, KM Williams, RO Day, ...
Journal of Antimicrobial Chemotherapy 75 (11), 3293-3302, 2020
132020
Cannabinoid disposition after human intraperitoneal use: an insight into intraperitoneal pharmacokinetic properties in metastatic cancer
CJ Lucas, P Galettis, S Song, N Solowij, SE Reuter, J Schneider, ...
Clinical therapeutics 40 (9), 1442-1447, 2018
122018
Pharmacokinetics and comparative bioavailability of artesunate and mefloquine administered separately or as a fixed combination product to healthy volunteers and patients with …
P Olliaro, S Ramanathan, M Vaillant, SE Reuter, AM Evans, S Krudsood, ...
J Bioequiv Availab 2 (3), 59-66, 2010
122010
Evaluation of a pilot vancomycin precision dosing advisory service on target exposure attainment using an interrupted time series analysis
SL Stocker, JE Carland, SE Reuter, AE Stacy, AL Schaffer, M Stefani, ...
Clinical Pharmacology & Therapeutics 109 (1), 212-221, 2021
92021
Comparison of the area under the curve for vancomycin estimated using compartmental and noncompartmental methods in adult patients with normal renal function
RV Shingde, GG Graham, SE Reuter, JE Carland, RO Day, SL Stocker
Therapeutic drug monitoring 41 (6), 726-731, 2019
72019
Inability of current dosing to achieve carboplatin therapeutic targets in people with advanced non-small cell lung cancer: impact of systemic inflammation on carboplatin …
BDW Harris, V Phan, V Perera, A Szyc, P Galettis, JH Martin, E Walpole, ...
Clinical Pharmacokinetics 59 (8), 1013-1026, 2020
62020
The system can't perform the operation now. Try again later.
Articles 1–20